首页> 外文期刊>Cryobiology: International Journal of Low Temperature Biology and Medicine >Subzero nonfreezing cryopresevation of rat hearts using antifreeze protein I and antifreeze protein III.
【24h】

Subzero nonfreezing cryopresevation of rat hearts using antifreeze protein I and antifreeze protein III.

机译:使用抗冻蛋白I和抗冻蛋白III对大鼠心脏进行零以下的非冷冻低温冷冻。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the present study was to evaluate whether AFPs protect the heart from freezing and improve survival and viability in subzero cryopreservation. Hearts were subject to 5 preservation protocols; University of Wisconsin solution (UW) at 4 degrees C, UW at -1.3 degrees C without nucleation, UW at -1.3 degrees C with nucleation, UW AFP I (15mg/cm(3)) at -1.3 degrees C with nucleation, and in UW AFP III (15mg/cm(3)) at -1.3 degrees C with nucleation. Hearts were preserved for 24, 28, and 32h, rewarmed and connected to the working isolated perfusion system. Data [heart rate (HR), coronary flow (CF), and developed pressure (dP)] was collected 30 and 60min after reperfusion. Hearts preserved at -1.3 degrees C without AFPs froze, while hearts preserved with AFP did not freeze when nucleation was initiated and survived. Survival and dP of hearts preserved for 24h at -1.3 degrees C using AFP III was better than those preserved at 4 degrees C, (dP; 1.4 vs. 0.8, [Formula: see text] ). Four of six hearts and six of six hearts died when preserved at 4 degrees C for 28 and 32h, respectively, all of the hearts that were preserved at -1.3 degrees C with or without AFPs survived after 28h ( [Formula: see text] ) and 32h ( [Formula: see text] ). CF was higher in UW -1.3 degrees C group without attempted nucleation than in AFP I and AFP III groups after 28 and 32h (3.4 vs. 1.7, [Formula: see text], and 3.4 vs. 1.7, [Formula: see text], respectively). In conclusion, AFPs were found to protect the heart from freezing and improve survival and dP (AFP III) in prolonged subzero preservation.
机译:本研究的目的是评估AFP是否能保护心脏免受冰冻并提高零下冷冻保存的存活率和生存能力。心脏接受了5种保存方案;威斯康星大学溶液(UW)在4摄氏度下,UW在-1.3摄氏度下没有成核,UW在-1.3摄氏度下有成核,UW AFP I(15mg / cm(3))在-1.3摄氏度下有成核,以及在UW AFP III(15mg / cm(3))中于-1.3度成核。将心脏保存24、28和32小时,然后将其重新加热并连接到隔离的正常灌注系统。再灌注后30和60分钟收集数据[心率(HR),冠状动脉血流(CF)和发达压力(dP)]。保存在-1.3摄氏度且没有AFP冻结的心脏,而保存有AFP的心脏在开始成核并存活后并未冻结。使用AFP III在-1.3摄氏度下保存24h的心脏的存活率和dP优于在4摄氏度下保存的心脏的存活率和dP(dP; 1.4 vs. 0.8,[公式:见正文])。当分别在4摄氏度下保存28和32小时时,六分之四的心脏和六分之六的心脏死亡,所有在-1.3摄氏度下保存或不包含AFP的心脏都在28小时后存活([公式:参见文本])和32h([公式:请参见文字])。未尝试成核的UW -1.3°C组的CF高于28和32h后的AFP I和AFP III组(3.4 vs. 1.7,[公式:请参见文本],以及3.4 vs. 1.7,[Formula:请参见文本] , 分别)。总之,发现AFP可保护心脏免受冰冻,并延长零下保存时间,从而改善存活率和dP(AFP III)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号